Please login to the form below

Not currently logged in

UCB appoints new board members

Brussels-based biopharmaceutical company, UCB, has announced Bert De Graeve and Alexandre Van Damme as candidates for the Board

Brussels-based biopharmaceutical company, UCB, has announced Bert De Graeve and Alexandre Van Damme as candidates to join the Board at the company's general assembly on April 29.  After three terms on the Board, Prince Lorenz will step down at the forthcoming assembly. UCB's Board of Directors and Executive Committee thanked him for his contributions.

Bert De Graeve is chief executive officer of the Bekaert Group. He is also a member of the International Business Leaders' Advisory Council for the Mayor of Shanghai (IBLAC), president of the Flanders-China Chamber of Commerce, member of the advisory board of the Conference Board China Centre for Economics and Business in Beijing, member of the Board of the Concours Reine Elisabeth and senior member of the Conference Board New York.

Alexandre Van Damme is on the boards of Anheuser-Busch InBev and InBev-Baillet Latour (not-for-profit organisation). He is also a member of the INSEAD International Council and the Solvay Business School Consultative Council. Their appointments will broaden the skills of the Board. Following approval at the general assembly, the new Board will have eight independent members; Armand De Decker, Bert De Graeve, Peter Fellner, Jean-Pierre Kinet, Thomas Leysen, Tom McKillop, Gerhard Mayr, and Norman Ornstein.

The remaining members include Karel Boone, chairman, Evelyn du Monceau, vice chair, Roch Doliveux, executive director, Arnoud de Pret, Bridget van Rijckevorsel, Alexandre Van Damme and Gaëtan van de Werve. 

29th March 2010


Featured jobs

Subscribe to our email news alerts


Add my company
Life Healthcare Communications

Life is a creative communications agency offering multi-channel solutions for the healthcare industry. We use a storytelling approach to turn...

Latest intelligence

Waking the sleeping giant
The lights are coming on for healthcare delivery in Africa...
How to get rep buy-in for multi-channel
How do you manage a team who may be resistant to change?...
Blog: Digital therapeutics: within our reach?
Digital therapeutics is a hot topic right now. By using digital technology to manage, treat or even prevent chronic conditions, digital therapeutics is promising to revolutionise healthcare. But is this...